# FDA Inspection 1160435 - Octapharma Plasma Inc - December 16, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8233d46d-15c4-4686-8a57-7b33a3286ce4
Source feed: FDA_Inspections

> FDA Inspection 1160435 for Octapharma Plasma Inc on December 16, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160435
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-12-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1160435 - 2021-12-16](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/fae1ab8c-da98-46cc-aff1-e63146a27b41)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/276c443e-3b35-455f-aef5-80494cd10c09

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d